Neuroplast spinal cord injury study milestone
The trial analyses the impact of its ‘Neuro-Cells’ among patients with traumatic spinal cord injuries
Read More
Tag: Neuroplast
Neuroplast receives medicinal product designation for Neuro-Cells
Designation paves way for wider applications for several neurodegenerative diseases
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
